Modulatory effects of EPA and DHA on proliferation and apoptosis of pancreatic cancer cells

Abstract

In order to investigate the effects of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) on the proliferation, apoptosis of pancreatic cancer cell line SW1990 cells and the expression of cyclin E mRNA, the SW1990 cells were treated with different concentrations of EPA or DHA (20, 40, 60 μg/mL) for 0, 12, 24, 36 and 48 h respectively. By using MTT method, the inhibitory effects of EPA or DHA on the cell growth were assayed. Real time PCR was used to detect the expression changes of cyclin E mRNA after the SW1990 cells were treated with 40 μg/mL EPA or DHA for different time. Flow cytometry was used to test the changes of apoptostic rate in the SW1990 cells treated with different concentrations of EPA or DHA for 24 h. The results showed that EPA and DHA could inhibit the growth of SW1990 cells in a time-and concentration-dependent manner (P<0.01). EPA or DHA could also significantly inhibit the expression of cyclin E mRNA in a time-dependent manner (P<0.05). EPA or DHA could induce the apoptosis of SW1990 cells in a concentration-dependent manner (P<0.01). It was concluded that ω-3 fatty acid could inhibit the proliferation of pancreatic cancer cell line SW1990 cells and promote their apoptosis. The down-regulation of the cyclin E expression by ω-3 fatty acid might be one of the mechanisms for its anti-tumor effect on pancreatic cancer.

Keywords

ω-3 fatty acid / cyclin E / apoptosis / malignant tumor

References

[1] FernandezE., GallusS., La VecchiaC., et al.. Nutrition and cancer risk: an overview. J Br Menopause Soc, 2006, 12(4): 139-142

[2] TanakaH., KageyamaK., KimuraM., et al.. Promotive effects of hyperthermia on the inhibition of DNA synthesis in ehrlich ascites tumor cells by eicosapentaenoic and docosahexaenoic acids. Exp Oncol, 2006, 28(3): 203-208

[3] TsekosE., ReuterC., StehleP., et al.. Perioperative administration of parenteral fish oil supplements in a routine clinical setting improves patient outcome after major abdominal surgery. Clin Nutr, 2004, 23(3): 325-330

[4] DingW. Q., LindS. E.. Phospholipid hydroperoxide glutathione peroxidase plays a role in protecting cancer cells from docosahexaenoic acid-induced cytotoxicity. Mol Cancer Ther, 2007, 6(4): 1467-1474

[5] AleemE., KiyokawaH., KaldisP., et al.. Cdc2-cyclin E complexes regulate the G1/S phase transition. Nat Cell Biol, 2005, 7(8): 831-836

[6] LundbergA. S., WeibergR. A.. Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes. Mol Cell Biol, 1998, 18(11): 753-762

[7] RosenD. G., YangG., DeaversM. T., et al.. Cyclin E expression is correlated with tumor progression and predicts a poor prognosis in patients with ovarian carcinoma. Cancer, 2006, 106(9): 1925-1932

[8] SkalickyD. A., KenchJ. G., SegaraD., et al.. Cyclin E expression and outcome in pancreatic ductal adenocarcinoma. Cancer Epidemiol Biomarkers Prev, 2006, 15(10): 1941-1947

[9] HardmanW. E.. (n-3) fatty acids and cancer therapy. J Nutr, 2004, 134(12Suppl): 3427S-3430S

[10] DanbaraN., YuriT., Tsujita-KyutokuM., et al.. Conjugated docosahexaenoic acid is a potent inducer of cell cycle arrest and apoptosis and inhibits growth of colo 201 human colon cancer cells. Nutr Cancer, 2004, 50(1): 71-79